In the legal landscape of 2025, Ron Machen of WilmerHale has made significant headlines with his exemplary defense strategies in high-stakes litigation. His notable achievement in the recent patent infringement dispute between Gilead Sciences and the US Department of Justice exemplifies his strategic acumen. The case revolved around Gilead’s HIV prevention treatments, Truvada and Descovy, with the DOJ initially asserting a $3 billion claim. The dispute concluded with a settlement in January 2025, following favorable rulings for Gilead.
This legal battle was unparalleled, marking the first instance where the government pursued a pharmaceutical partner for such claims. Machen tactically countered by suing the government in the Court of Federal Claims for breach of agreements with Gilead. This maneuver not only mitigated potential liabilities but also positioned Gilead favorably for the jury trial, which also resulted in a decision favoring the pharmaceutical giant.
Machen emphasized their approach of transforming what initially appeared as a defensive posture into an offensive strategy, which allowed Gilead to leverage settlement discussions effectively, thus avoiding a lengthy appeal process. This outcome underscored Machen’s unwavering commitment to thorough preparation and his ability to swiftly adapt to on-the-fly developments during litigation.
A critical moment during the trial emerged when a government witness inadvertently undercut the government’s privilege claim over a crucial document. Machen’s rapid response in filing a motion overnight to access the unredacted document demonstrated his diligent approach. Eventually, the court ordered the release of pivotal portions of the document, which Machen used to weaken the government’s position further.
Holding fast to the philosophy of thorough preparation while remaining flexible, Machen advises young trial lawyers to anticipate and adapt to unexpected challenges in the courtroom. His career, influenced by early encouragement from influential figures like Judge Damon Keith, emphasizes the integration of legal expertise with compelling narrative and strategic foresight to win cases.
For more on Ron Machen’s esteemed legal career and his recognition in 2025, please visit Bloomberg Law.